SCHEMBL3209999

SCHEMBL3209999

CCOC(=O)C(C)N1CC=CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
DPP4 P27487 3/20 0.41
DPP8 Q6V1X1 2/20 0.41
DPP9 Q86TI2 1/20 0.41
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 2/20 0.38
DPP7 Q9UHL4 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LIPE Q05469 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13484645 1.00 TSHR (0.41) TSHRDPP4DPP8DPP9CYP2C19
SCHEMBL3205149 0.82 ALDH1A1 (0.45) TSHRDPP4DPP8DPP9CYP2C19
SCHEMBL13484647 0.82 ALDH1A1 (0.45) TSHRDPP4DPP8DPP9CYP2C19
SCHEMBL6129180 0.81 ALDH1A1 (0.46) TSHRCYP2C19CYP3A4ALDH1A1MAPT
SCHEMBL4089646 0.78 ALDH1A1 (0.43) TSHRCYP2C19CYP3A4ALDH1A1MAPT
SCHEMBL28201107 0.78 ALDH1A1 (0.43) TSHRCYP2C19CYP3A4ALDH1A1MAPT
SCHEMBL3898658 0.78 ALDH1A1 (0.43) TSHRCYP2C19CYP3A4ALDH1A1MAPT
SCHEMBL3353702 0.77 ALDH1A1 (0.40) TSHRCYP2C19CYP3A4ALDH1A1MAPT
SCHEMBL2961890 0.76 ALDH1A1 (0.42) CYP2C19CYP3A4ALDH1A1MAPTLMNA
SCHEMBL13472662 0.74 ALDH1A1 (0.46) TSHRCYP2C19CYP3A4ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-02-04 US claimed
EP-2029536-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-03-04 EP claimed
WO-2007128458-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-11-15 WO claimed
EP-2029536-B1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS ESTEVE LABOR DR (ES) 2013-08-28 EP disclosed
US-8299113-B2 Bicyclic tetrahydropyrrole compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-10-30 US disclosed
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-02-04 US disclosed
EP-2029536-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-03-04 EP disclosed
WO-2007128458-A1 BICYCLIC TETRAHYDROPYRROLE COMPOUNDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029738-A1 Bicyclic Tetrahydropyrrole Compounds CYP11B2, CYP11B1, SDHA TSHR 1821/4885DPP4 2838/4885DPP8 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.